Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (11/18/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Familial Pheochromocytoma and Paraganglioma Syndrome

Added level of evidence 4 for the surveillance of patients with familial pheochromocytoma and paraganglioma syndrome.

Carney-Stratakis Syndrome

Added level of evidence 4 for the surveillance of patients with Carney-Stratakis syndrome.

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Carney-Stratakis Syndrome

Next section >
About This PDQ Summary